|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
Chemistry
| Test | 12-SEP-2024 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 70.6 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 15.4 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.2 H | 0.6 - 1.2 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 9.8 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 138.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 5.2 H | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 110.4 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 21.5 L | 22 - 32 | mmol/L |
| Ketones [Presence] in Urine by Test strip | Urine ketone test negative | ||
| Hemoglobin A1c/Hemoglobin.total in Blood | 3.3 L | 4.0 - 5.6 | % |
| Glucose [Mass/volume] in Blood | 70.6 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 15.4 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 39.8 H | 0.6 - 1.2 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.8 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 138.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 5.2 H | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 110.4 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 21.5 L | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 231.0 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 145.6 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 142.8 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 59.1 | 40 - 60 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 555.1 H | 0 - 30 | mg/g |
Urinalysis
| Test | 12-SEP-2024 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Urine by Test strip | 1.1 | 0 - 5 | mg/dL |
| Glucose [Presence] in Urine by Test strip | Urine glucose test = ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 1.5 H | 0 - 1 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 8.8 | 0 - 20 | mg/dL |
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.030 | {nominal} |
| pH of Urine by Test strip | 5.0 | 5.0 - 8.0 | pH |
| Protein [Mass/volume] in Urine by Test strip | 288.9 H | 0 - 20 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = +++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative |
Specimen information
| Test | 12-SEP-2024 | Specimen | |
|---|---|---|---|
| Appearance of Urine | Cloudy urine | Urine | |
| Odor of Urine | Urine smell ammoniacal | Urine | |
| Clarity of Urine | Translucent | Urine | |
| Color of Urine | Brown color | Urine |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows markedly elevated creatinine, proteinuria, microalbuminuria, and abnormal electrolytes, indicating significant renal dysfunction, likely chronic kidney disease. Urinalysis reveals protein, glucose, bilirubin, ketones, and abnormal appearance, supporting renal pathology. Low HbA1c suggests no chronic hyperglycemia. Dyslipidemia is present. Immediate nephrology evaluation is recommended for further assessment and management of renal impairment and associated metabolic disturbances. |